Koyfin Home > Directory > Health Care > Amicus Therapeutics > Long-Term Investments

Amicus Therapeutics Long-Term Investments Chart (FOLD)

Amicus Therapeutics annual/quarterly Long-Term Investments from 2014 to 2018.
  • Amicus Therapeutics Long-Term Investments for the quarter ending June 06, 2018 was $14m a -11.51% decrease of -2m year over year
  • Amicus Therapeutics Long-Term Investments for the last 12 months ending June 06, 2018 was $14m a -11.51% decrease of -2m year over year
Other Cash Flow Metrics:
  • Amicus Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $-133m a 44.44% decrease of -59m year over year
  • Amicus Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-78m a 35.32% decrease of -28m year over year
  • Amicus Therapeutics Total Revenue for the quarter ending September 09, 2018 was $21m a 28.49% increase of 6m year over year
View Chart On Koyfin

Quarterly FOLD Long-Term Investments Data

06/2018$14m
03/2018$43m
09/2017$15m
09/2015$15m
03/2015$3m
12/2014$17m

Annual FOLD Long-Term Investments Data

2014$17m